Androgen receptor represses the neuroendocrine transdifferentiation process in prostate cancer cells.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Molecular Endocrinology

• Publication date

  2003-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1210/ME.2003-0031PMID 12775765
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Culture of Animal Cells: A Manual of Basic Technique and Specialized Applications

  2010cited by this paper
• Target Antigens for Prostate Cancer Immunotherapy

  2004cited by this paper
• Biology of prostate-specific antigen.

  2003cited by this paper
• BIOLOGY OF PROSTATESPECIFIC ANTIGEN

  2003cited by this paper
• Transition to androgen-independence in prostate cancer.

  2002cited by this paper
• Molecular biology of the androgen receptor.

  2002cited by this paper
• Disruption of androgen receptor function inhibits proliferation of androgen-refractory prostate cancer cells.

  2002cited by this paper
• The role of androgens and the androgen receptor in prostate cancer.

  2002cited by this paper
• Androgen receptor as a target in androgen-independent prostate cancer.

  2002cited by this paper
• Rescue of polyglutamine-mediated cytotoxicity by double-stranded RNA-mediated RNA interference.

  2002cited by this paper
• Multipathways for transdifferentiation of human prostate cancer cells into neuroendocrine-like phenotype.

  2001cited by this paper
• Molecular Biology of the Androgen Receptor: From Molecular Understanding to the Clinic

  2001cited by this paper
• Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells

  2001cited by this paper
• Androgen receptor expression in androgen‐independent prostate cancer cell lines

  2001cited by this paper
• Androgen receptor stabilization in recurrent prostate cancer is associated with hypersensitivity to low androgen.

  2001cited by this paper
• Androgens stimulate lipogenic gene expression in prostate cancer cells by activation of the sterol regulatory element-binding protein cleavage activating protein/sterol regulatory element-binding protein pathway.

  2001cited by this paper
• Molecular biology of the androgen receptor.

  2000cited by this paper
• Inhibition of LNCaP prostate cancer cells by means of androgen receptor antisense oligonucleotides

  2000cited by this paper
• Testosterone and estrogen affect neuronal differentiation but not proliferation in early embryonic cortex of the rat: the possible roles of androgen and estrogen receptors.

  2000cited by this paper
• Molecular genetics of prostate cancer.

  2000cited by this paper
• Androgen‐independent growth is induced by neuropeptides in human prostate cancer cell lines

  2000cited by this paper
• Hormone therapy for patients with prostate carcinoma

  2000cited by this paper
• Evidence for clonal outgrowth of androgen-independent prostate cancer cells from androgen-dependent tumors through a two-step process.

  1999cited by this paper
• Neuroendocrine differentiation in prostatic carcinoma

  1999cited by this paper
• Molecular mechanisms of androgen-independent growth of human prostate cancer LNCaP-AI cells.

  1999cited by this paper
• Transdifferentiation of prostate cancer cells to a neuroendocrine cell phenotype in vitro and in vivo.

  1999cited by this paper
• Progression of LNCaP prostate tumor cells during androgen deprivation: hormone-independent growth, repression of proliferation by androgen, and role for p27Kip1 in androgen-induced cell cycle arrest.

  1998cited by this paper
• RNA as a target of double-stranded RNA-mediated genetic interference in Caenorhabditis elegans.

  1998cited by this paper
• Fas ligand is constitutively secreted by prostate cancer cells in vitro.

  1998cited by this paper
• Neuroendocrine cells in benign prostatic hyperplasia and prostatic carcinoma: effect of hormonal treatment.

  1997cited by this paper
• Immortalized and tumorigenic adult human prostatic epithelial cell lines: Characteristics and applications part 2. Tumorigenic cell lines

  1997cited by this paper
• Characterization of developmental stage and neuronal potential of the rat PNS-derived stem cell line, RT4-AC.

  1996cited by this paper
• Molecular mechanisms of androgen action.

  1994cited by this paper
• Independent regulatory elements in the nestin gene direct transgene expression to neural stem cells or muscle precursors.

  1994cited by this paper
• Glial Fibrillary Acidic Protein: Regulation by Hormones, Cytokines, and Growth Factors

  1994cited by this paper
• Androgen receptor phosphorylation, turnover, nuclear transport, and transcriptional activation. Specificity for steroids and antihormones.

  1992cited by this paper
• Androgen regulation of programmed death of normal and malignant prostatic cells.

  1992cited by this paper
• The human prostatic cancer cell line LNCaP and its derived sublines: an in vitro model for the study of androgen sensitivity.

  1991cited by this paper
• CNS stem cells express a new class of intermediate filament protein.

  1990cited by this paper
• The use of cell lines in neurobiology.

  1990cited by this paper
• Partial characterization of a thyroid‐stimulating hormone‐like peptide in neuroendocrine cells of the human prostate gland

  1989cited by this paper
• Proliferation and differentiation of rat neuroepithelial precursor cells in vivo

  1988cited by this paper
• Glial fibrillary acidic protein (GFAP): the major protein of glial intermediate filaments in differentiated astrocytes.

  1985cited by this paper
• Radical prostatectomy for the treatment of localized prostatic carcinoma.

  1980cited by this paper
• Studies on prostatic cancer. I. The effect of castration, of estrogen and androgen injection on serum phosphatases in metastatic carcinoma of the prostate.

  1941cited by this paper
• Printed in U.S.A. Copyright © 1999 by The Endocrine Society Molecular Mechanisms of Androgen-Independent Growth of Human Prostate Cancer LNCaP-AI Cells*

  year unknowncited by this paper

• Mechanisms of neuroendocrine differentiation in castration-resistant prostate cancer and advances in the treatment of neuroendocrine prostate cancer

  2025cites this paper
• Impact of sex hormones on development and progression in NEN: a new therapeutic target?

  2025cites this paper
• Neuroendocrine differentiation in prostate neoplasms

  2025cites this paper
• CYB561 supports the neuroendocrine phenotype in castration-resistant prostate cancer

  2024cites this paper
• Dynamic assessment of serum chromogranin A and treatment response with abiraterone acetate in metastatic castration‐resistant prostate cancer

  2023cites this paper
• Loss of PDE4D7 expression promotes androgen independence, neuroendocrine differentiation and alterations in DNA repair: implications for therapeutic strategies

  2023cites this paper
• Targeting PKLR/MYCN/ROMO1 signaling suppresses neuroendocrine differentiation of castration-resistant prostate cancer.

  2023cites this paper
• Targeting hormone-resistant breast cancer cells with docetaxel: a look inside the resistance

  2023cites this paper
• Histologic transformation in lung cancer: when one door shuts, another opens

  2022cites this paper
• Androgens regulate CALCA gene expression in the prostate by methylation of CALCA Promoter

  2022cites this paper
• ETS transcription factor ELF3 (ESE‐1) is a cell cycle regulator in benign and malignant prostate

  2022cites this paper
• Androgen Receptor Splice Variants Contribute to the Upregulation of DNA Repair in Prostate Cancer

  2022cites this paper
• Neuropilin-2 axis in regulating secretory phenotype of neuroendocrine-like prostate cancer cells and its implication in therapy resistance

  2022cites this paper
• Androgen Receptor Signaling in Prostate Cancer Genomic Subtypes

  2021cites this paper
• Zeb1 and SK3 Channel Are Up-Regulated in Castration-Resistant Prostate Cancer and Promote Neuroendocrine Differentiation

  2021cites this paper
• Racial differences in androgen metabolism and receptor signaling in prostate cancer

  2021cites this paper
• Patient-derived xenograft models of neuroendocrine prostate cancer.

  2021cites this paper
• Multi-omic analysis of lung tumors defines pathways activated in neuroendocrine transformation

  2020cites this paper
• A mechanism for epithelial-mesenchymal heterogeneity in a population of cancer cells

  2020cites this paper
• Wnt/Beta-Catenin Signaling and Prostate Cancer Therapy Resistance.

  2019cites this paper
• Aggressive variants of prostate cancer - Are we ready to apply specific treatment right now?

  2019cites this paper
• PEG10 is associated with treatment-induced neuroendocrine prostate cancer.

  2019cites this paper
• Drug-induced liver injury

  2019cites this paper
• hASH1 nuclear localization persists in neuroendocrine transdifferentiated prostate cancer cells, even upon reintroduction of androgen

  2019cites this paper
• A Mechanism for Epithelial-Mesenchymal Heterogeneity in a Population of Cancer Cells

  2019cites this paper
• Preliminary efficacy and tolerability of chemohormonal therapy in metastatic hormone‐naïve prostate cancer: The first real‐life experience in Asia

  2018cites this paper
• The Colorful Palette of Neuroendocrine Neoplasms in the Genitourinary Tract

  2018cites this paper
• Neuroendocrine Differentiation in Prostate Cancer: Emerging Biology, Models, and Therapies.

  2018cites this paper
• Heterochromatin Protein 1α Mediates Development and Aggressiveness of Neuroendocrine Prostate Cancer.

  2018cites this paper
• The role of serum neuron-specific enolase in patients with prostate cancer: a systematic review of the recent literature

  2018cites this paper
• Molecular model for neuroendocrine prostate cancer progression

  2018cites this paper
• Androgen receptor signaling regulates T-type Ca2+ channel expression and neuroendocrine differentiation in prostate cancer cells.

  2018cites this paper
• The role of the ETS factor ELF3 in the normal and malignant prostate

  2018cites this paper
• Foxa2 activates the transcription of androgen receptor target genes in castrate resistant prostatic tumors.

  2018cites this paper
• Prostate-specific markers to identify rare prostate cancer cells in liquid biopsies

  2018cites this paper
• EMT, stemness and tumor plasticity in aggressive variant neuroendocrine prostate cancers.

  2018cites this paper
• GABA promotes gastrin-releasing peptide secretion in NE/NE-like cells: Contribution to prostate cancer progression

  2018cites this paper
• Lineage plasticity-mediated therapy resistance in prostate cancer

  2018cites this paper
• MYC regulates ductal-neuroendocrine lineage plasticity in pancreatic ductal adenocarcinoma associated with poor outcome and chemoresistance

  2017cites this paper
• Folate-targeted nanoparticle delivery of androgen receptor shRNA enhances the sensitivity of hormone-independent prostate cancer to radiotherapy.

  2017cites this paper
• Molecular Pathogenesis of Prostate Cancer

  2017cites this paper
• Micro-RNA-204 Participates in TMPRSS2/ERG Regulation and Androgen Receptor Reprogramming in Prostate Cancer

  2017cites this paper
• Midkine in Advanced Prostate Cancer - Biological Impact and Biomarker Potential

  2017cites this paper
• Targeting CXCR2+ Neuroendocrine-like Cells for the Treatment of Castration-resistant Prostate Cancer

  2017cites this paper
• Implications of PI3K/AKT inhibition on REST protein stability and neuroendocrine prostate cancer

  2017cites this paper
• Elucidation of AR impact on the paternally expressed Gene 10 (PEG10) in Enzalutamide-resistant prostate cancer

  2016cites this paper
• Up-Regulated Expression of LAMP2 and Autophagy Activity during Neuroendocrine Differentiation of Prostate Cancer LNCaP Cells

  2016cites this paper
• The dual regulatory role of miR-204 in cancer

  2016cites this paper
• N-Myc Induces an EZH2-Mediated Transcriptional Program Driving Neuroendocrine Prostate Cancer.

  2016cites this paper
• c-MYC drives histone demethylase PHF8 during neuroendocrine differentiation and in castration-resistant prostate cancer

  2016cites this paper
• Icaritin suppresses development of neuroendocrine differentiation of prostate cancer through inhibition of IL-6/STAT3 and Aurora kinase A pathways in TRAMP mice.

  2016cites this paper
• ORTI: An Open-Access Repository of Transcriptional Interactions for Interrogating Mammalian Gene Expression Data

  2016cites this paper
• The oncogene ERG: a key factor in prostate cancer

  2016cites this paper
• Effects of Hormonal Withdrawal on Prostate Cancer Progression

  2016cites this paper
• Dichotomy in the Epigenetic Mark Lysine Acetylation is Critical for the Proliferation of Prostate Cancer Cells

  2015cites this paper
• Anti‐androgen enzalutamide enhances prostate cancer neuroendocrine (NE) differentiation via altering the infiltrated mast cells → androgen receptor (AR) → miRNA32 signals

  2015cites this paper
• UK single centre experience of rare and atypical variant of castrate-resistant prostate cancer: Poorly differentiated neuroendocrine small-cell carcinoma

  2015influential citation
• Expression and Functional Role of Orphan Receptor GPR158 in Prostate Cancer Growth and Progression

  2015cites this paper
• Posttranscriptional regulation of T-type Ca(2+) channel expression by interleukin-6 in prostate cancer cells.

  2015cites this paper
• A dual yet opposite growth-regulating function of miR-204 and its target XRN1 in prostate adenocarcinoma cells and neuroendocrine-like prostate cancer cells

  2015cites this paper
• MicroRNA-185 downregulates androgen receptor expression in the LNCaP prostate carcinoma cell line.

  2015cites this paper
• Small cell carcinoma of the prostate

  2014cites this paper
• The Steroid Receptor Coactivator-3 Is Required for Developing Neuroendocrine Tumor in the Mouse Prostate

  2014cites this paper
• miR-204 Shifts the Epithelial to Mesenchymal Transition in Concert with the Transcription Factors RUNX2, ETS1, and cMYB in Prostate Cancer Cell Line Model

  2014cites this paper
• The Many Faces of Neuroendocrine Differentiation in Prostate Cancer Progression

  2014cites this paper
• Neuroendocrine Prostate Cancer (NEPC) progressing from conventional prostatic adenocarcinoma: factors associated with time to development of NEPC and survival from NEPC diagnosis-a systematic review and pooled analysis.

  2014cites this paper
• Undifferentiated Prostate Cancer and the Neuroendocrine Phenotype

  2014cites this paper
• Androgen-Targeted Therapy-Induced Epithelial Mesenchymal Plasticity and Neuroendocrine Transdifferentiation in Prostate Cancer: An Opportunity for Intervention

  2014cites this paper
• The role of transcription factors in prostate cancer and potential for future RNA interference therapy

  2014cites this paper
• The lysine demethylase, KDM4B, is a key molecule in androgen receptor signalling and turnover

  2013cites this paper
• Estrogen receptor β expression and androgen receptor phosphorylation correlate with a poor clinical outcome in hormone-naive prostate cancer and are elevated in castration-resistant disease.

  2013cites this paper
• Cross modulation between the androgen receptor axis and protocadherin-PC in mediating neuroendocrine transdifferentiation and therapeutic resistance of prostate cancer.

  2013cites this paper
• Concurrent AURKA and MYCN gene amplifications are harbingers of lethal treatment-related neuroendocrine prostate cancer.

  2013cites this paper
• AKT upregulates B-Raf Ser445 phosphorylation and ERK1/2 activation in prostate cancer cells in response to androgen depletion.

  2013cites this paper
• Midkine is associated with neuroendocrine differentiation in castration‐resistant prostate cancer

  2013cites this paper
• Neuroendocrine Differentiation in Prostate Cancer

  2013cites this paper
• Formation of Secretory Senescent Cells in Prostate Tumors: The Role of Androgen Receptor Activity and Cell Cycle Regulation

  2013cites this paper
• Molecular aspects of androgenic signaling and possible targets for therapeutic intervention in prostate cancer.

  2013cites this paper
• [Cushing syndrome and prostate cancer recurrence with undetectable prostate-specific antigen].

  2013cites this paper
• Integration of Regulatory Networks by NKX3-1 Promotes Androgen-Dependent Prostate Cancer Survival

  2012cites this paper
• Androgen receptor (AR) expression in prostate cancer and progression of the tumor: Lessons from cell lines, animal models and human specimens.

  2012cites this paper
• Carbidopa abrogates L‐dopa decarboxylase coactivation of the androgen receptor and delays prostate tumor progression

  2012cites this paper
• Bypassing androgen pathway dependence in advanced prostate cancer.

  2012cites this paper
• Transdifferentiation: a cell and molecular reprogramming process

  2012cites this paper
• Award Number: W81XWH-08-1-0394 TITLE: Interplay of CREB and ATF2 in Ionizing Radiation-Induced Neuroendocrine Differentiation of Prostate Cancer Cells

  2012cites this paper
• Ionizing radiation induces neuroendocrine differentiation of prostate cancer cells in vitro, in vivo and in prostate cancer patients.

  2011cites this paper
• miR 488* inhibits androgen receptor expression in prostate carcinoma cells

  2011cites this paper
• Transgenic Adenocarcinoma of the Mouse Prostate: A Validated Model for the Identification and Characterization of Molecular Targets and The Evaluation of Therapeutic Agents

  2011cites this paper
• Androgen-sensitive microsomal signaling networks coupled to the proliferation and differentiation of human prostate cancer cells.

  2011cites this paper
• The Raf/MEK/extracellular signal-regulated kinase 1/2 pathway can mediate growth inhibitory and differentiation signaling via androgen receptor downregulation in prostate cancer cells.

  2011cites this paper
• Biomarqueurs émergents dans le cancer de prostate : à propos de la β-tubuline de classe III et du score urinaire PCA3

  2011cites this paper
• Original Article Ionizing radiation induces neuroendocrine differentiation of prostate cancer cells in vitro, in vivo and in prostate cancer patients

  2011cites this paper
• Minireview: Alternative activation pathways for the androgen receptor in prostate cancer.

  2011cites this paper
• Ethnic differences in neuroendocrine expression in prostate cancer tissue.

  2011cites this paper
• Neuroendocrine differentiation in prostate carcinoma: focusing on its pathophysiologic mechanisms and pathological features.

  2010cites this paper
• Molecular Targeting of Prostate Cancer During Androgen Ablation: Inhibition of CHES1/FOXN3

  2010cites this paper
• Snail transcription factor regulates neuroendocrine differentiation in LNCaP prostate cancer cells

  2010cites this paper
• An integrated network of androgen receptor, polycomb, and TMPRSS2-ERG gene fusions in prostate cancer progression.

  2010cites this paper
• Androgen-responsive and -unresponsive prostate cancer cell lines respond differently to stimuli inducing neuroendocrine differentiation.

  2010cites this paper
• Small-cell carcinoma of prostate: A case report and literature review

  2010influential citation